YD BIO LTD (YDES) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:YDES • KYG983011076

11.3 USD

+0.27 (+2.45%)

Last: Jan 30, 2026, 11:51 AM

Fundamental Rating

Taking everything into account, YDES scores 3 out of 10 in our fundamental rating. YDES was compared to 525 industry peers in the Biotechnology industry. YDES scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. YDES is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

YDES had negative earnings in the past year.

1.2 Ratios

YDES's Return On Assets of -24.17% is fine compared to the rest of the industry. YDES outperforms 72.00% of its industry peers.
The Return On Equity of YDES (-27.74%) is better than 78.48% of its industry peers.

		Industry Rank	Sector Rank
ROA	-24.17%
ROE	-27.74%
ROIC	N/A

ROA(3y)-12.91%

ROA(5y)N/A

ROE(3y)-169.51%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of YDES (30.45%) is better than 72.95% of its industry peers.
YDES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	30.45%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

YDES does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, YDES has about the same amount of shares outstanding.
The debt/assets ratio for YDES has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 618.45 indicates that YDES is not in any danger for bankruptcy at the moment.
YDES has a better Altman-Z score (618.45) than 100.00% of its industry peers.
There is no outstanding debt for YDES. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	618.45

ROIC/WACCN/A

WACC8.9%

2.3 Liquidity

YDES has a Current Ratio of 1.86. This is a normal value and indicates that YDES is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of YDES (1.86) is worse than 77.33% of its industry peers.
A Quick Ratio of 1.36 indicates that YDES should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.36, YDES is doing worse than 81.14% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.86
Quick Ratio	1.36

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

YDES shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10100.00%.
YDES shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.79%.

EPS 1Y (TTM)-10100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1082.61%

Revenue 1Y (TTM)45.79%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%27.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.